Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Crossref DOI link: https://doi.org/10.1007/s00432-016-2134-3
Published Online: 2016-02-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rabitsch, W.
Bojic, M.
Wohlfarth, P.
Leiner, M.
Schörgenhofer, C.
Kalhs, P.
Schulenburg, A.
Sillaber, C.
Mitterbauer, M.
Sperr, W. R.
Jäger, U.
Skrabs, K.
Greinix, H.
Hermann, A.
Lamm, W.
License valid from 2016-02-26